Virulence Determinants of Acinetobacter baumannii Isolated from Different Infections in Baghdad Hospitals


  • Sajad Numan Clinical Laboratory Sciences, Pharmacy college, Mustansiriyah University, Iraq
  • Fitua Al-Saedi Clinical Laboratory Sciences, Pharmacy college, Mustansiriyah University, Iraq
  • Israa Burhan Clinical Laboratory Sciences, Pharmacy college, Mustansiriyah University, Iraq
  • Mojtaba Mohammadzadeh Vazifeh Department of Microbial Biotechnology,Faculty of Basic Sciences and Advanced Technologles in Biology, University ofScience and Culture, Tehran, Iran



Acinetobacter baumannii, antibiotics resistance, virulence factors


Acinetobacter baumannii is an essential pathogenic bacteria cause nosocomial infections worldwide. The current work aimed to characterize several virulence factors in Acintobacter baumannii isolated from diverse clinical specimens in Baghdad.

Clinical samples including sputum, blood, urine, CSF and wound swabs were collected from patients who were admitted to hospitals in Baghdad. Identification of Acinetobacter baumannii isolates was performed using Vitek 2 system. Phospholipase (plcN) and elastase (lasB) genes were identified using Polymerase chain reaction (PCR) technique. Other virulence factors such as motility, biofilm formation,hemolysin  production were screened.

Sixty-nine isolates were identified as Acinetobacter baumannii. The isolates were screened for Phospholipase (plcN) and elastase (lasB) production.The results of amplification revealed that out of the total  isolates, 18 (26.6%) isolates included both (plcN) and (lasB) genes, 18(26.6%) isolates included only (plcN) and 23(33.3%)  isolates have only (lasB).

Sixty (86.9%) isolates were positive for biofilm formation, 8 (11.6%) isolates indicated intermediate biofilm producers and 52(75.4%) isolates were weak biofilm producers. Sixty six  A.baumannii isolates were motile on Nutrient agar (0.3%). Sixteen isolates were intermediate motile and 50 were highly motile. Positive association was found between the biofilm formation capacity and surface associated motility.

Fifty-seven isolates showed hemolysis on Blood agar on the second day of the incubation. Of these, 48 (69.56%) isolates show β –hemolysis and 9 (13.04%) isolates show α-hemolysis,


- Lin, M. F., and Lan, C. Y. Antimicrobial resistance in Acinetobacter baumannii: from bench to bedside. World J. Clin. Cases. 2014; 2, 787–814.

- Peleg, A. Y., Seifert, H., and Paterson, D. L. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 2008; 21, 538–582.

- Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009; 4:273-8.

- Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist 2018; 11:2277-99.

- McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Lett 2013; 37:130-55.

- Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 2018; 16:91-102.

- Selvy PE, Lavieri RR, Lindsley CW, Brown HA. Phospholipase D: enzymology, functionality, and chemical modulation. Chem Rev. 2011; 111: 6064–6119.

- Chen CL, Dudek A, Liang YH, Janapatla RP, Lee HY, Hsu L, d-mannose-sensitive pilus of Acinetobacter baumannii is linked to biofilm formation and adherence onto respiratory tract epithelial cells. Journal of Microbiology, Immunology and Infection. 2021; 10(2):24-38

- Camarena L, Bruno V, Euskirchen G, Poggio S, Snyder M. Molecular mechanisms of ethanol-induced pathogenesis revealed by RNAsequencing. PLoS Pathog. 2010; 6: e1000834. doi: 10.1371/journal.ppat.1000834

- Stahl J, Bergmann H, Göttig S, Ebersberger I, Averhoff B. Acinetobacter baumannii virulence is mediated by the concerted action of three phospholipases D. PLoS ONE 2015; 10:e0138360. doi: 10.1371/journal.pone. 0138360

- Lee J, Choi C, Kang Y, et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. The Journal of antimicrobial chemotherapy. 2007; 59(4):633-639.Doi:10.1093/jac/dkm007.

- Al-Saedi, F. Strategies in anti-adhesion therapy: A review article. Al Mustansiriyah Journal of Pharmaceutical Sciences, 2021; 21(1).

- AL-Araji KM. Attachment of Proteus mirabilis to human urinary sediment epithelial cells in vitro. Al Mustansiriyah Journal of Pharmaceutical Sciences, 2005; 2 (2).

- Gunn JS, Bakaletz LO, Wozniak DJ. What’s on the outside matters: the role of the extracellular polymeric substance of Gram-negative biofilms in evading host immunity and as a target for therapeutic intervention. J Biol Chem. 2016;291(24):12538-12546.

- Ramos-Gallardo G. Chronic wounds in burn injury: a case report on importance of biofilms. World J Plast Surg. 2016;5(2):175.

- Wilharm G, Piesker J, Laue M, Skiebe E . DNA uptake bythe nosocomial pathogen Acinetobacter baumannii occurs during movement along wet surfaces. J Bacteriol. 2013;195(18):4146–4153.

- Harding CM, Tracy EN, Carruthers MD, Rather PN, Actis LA, Munson RS Jr. Acinetobacter baumannii strain M2 produces type IV pili which play a role in natural transformation and twitching motility but not surface-associated motility. MBio. 2013; https :// -13

- Mussi MA, Gaddy JA, Cabruja M, Arivett BA, Viale AM, Rasia R, Actis LA The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J Bacteriol. 2010);192(24):6336–6345.

- Clemmer KM, Bonomo RA, Rather PN. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology. 2011;157(Pt 9):2534.

- Eijkelkamp BA, Hassan KA, Paulsen IT, Brown MH Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. BMC Genomics (2011) 12:126.

- McQueary CN, Kirkup BC, Si Y, Barlow M, Actis LA, Craft DW, Zurawski DV. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility. J Microbio.2012 ;50 :434-43

- McQueary CN, Kirkup BC, Si Y, Barlow M, Actis LA, Craft DW et al. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility. J Microbiol.2012;50(3):434–443.

- Eijkelkamp BA, Stroeher UH, Hassan KA, Elbourne LD, Paulsen IT, Brown MH. H-NS plays a role in expression of Acinetobacter baumannii virulence features. Infect Immun. 2013;81(7):2574–2583.

- Pérez-Varela M, Corral J, Vallejo JA, Rumbo-Feal S, Bou G, Aranda J, Barbé J. Mutants in the β-subunit of the RNA polymerase impairing the surface-associated motility and virulence of Acinetobacter baumannii. Infect Immun. 2017; 85:8.

- Pérez-Varela M, Corral J, Aranda J, Barbé J. Roles of efflux pumps from different superfamilies in the surface-associated motility and virulence of

Acinetobacter baumannii ATCC 17978. Antimicrob Agents Chemother. 2019;63(3).

- Bazzi AM, Rabaan AA, Fawarah MM, Al-Tawfiq JA. Direct identification and susceptibility testing of positive blood cultures using high speed cold centrifugation and Vitek II system. J Infect Public Health. 2017;10(3):299-307

- Babapour E, Haddadi A, Mirnejad R. , Angaji, S , & Amirmozafari N. Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pacific Journal of Tropical Biomedicine. 2016;6 (6).

- Aliramezani A, Soleimani M, Fard RMN, Nojoomi F. Virulence determinants and biofilm formation of Acinetobacter baumannii isolated from hospitalized patients. Germs. 2019 Sep 2; 9(3):148-153

- Doughari HJ, Ndakidemi PA, Human IS, Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ 2011; 26:101-12.

- Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist 2018; 11:1249-60.

- Nocera FP, Attili AR, De Martino L. Acinetobacter baumannii: Its Clinical Significance in Human and Veterinary Medicine. Pathogens. 2021:27;10(2):127.

- Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist 2018; 11:2277-99.

- Kareem SM, Al-Kadmy IMS, Al-Kaabi MH, Acinetobacter baumannii virulence is enhanced by the combined presence of virulence factors genes phospholipase C (plcN) and elastase (lasB). Microb Pathog 2017; 110:568-72.

- Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun.2009;77, 3150–3160.

- Donlan RM. Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms.Clin. Microbiol. Rev. 2002;15, 167–193.

- Yang CH, Su PW, Moi SH, Chuang LY. Biofilm formation in Acinetobacter baumannii: Genotype-phenotype correlation. Molecules. 2019; 24, 1849

- Gedefie A, Demsis W, Ashagrie M, Kassa Y, Tesfaye M, Tilahun M,, Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review. Infect Drug Resist. 2021;10; 14:3711-3719.

- Fattahian Y, Rasooli I, Gargari M, Rahbar MR, Astaneh SDA, Amani J. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb. Pathog. 2011;51, 402–406.

- Aliramezani A, Douraghi M, Hajihasani A, Mohammadzadeh M, Rahbar M. Clonal relatedness and biofilm formation of OXA-23-producing carbapenem resistant Acinetobacter baumannii isolates from hospital environment. Micobial. Pathog. 2016; 99, 204–208.

- Loehfelm T.W, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J. Bacteriol. 2008, 190, 1036–1044.

- Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect. Immun. 2012, 80, 228–233.

- Lee HW, Kim J, Lee JC, LeeYC, Seol SY. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 2008, 14, 49–54.

- Cincarova L, Polansky O, Babak V, Kulich P, Kralik P. Changes in the Expression of biofilm-associated surface proteins in Staphylococcus aureus food-environmental isolates subjected to sublethal concentrations of disinfectants. Biomed. Res. Int. 2016, 4034517.

- Tomaras AP, Flagler MJ,Dorsey CW, Gaddy JA, Actis, LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiol. 2008, 154, 3398–3409.

- Leung E.C.M, Leung P.H.M, Lai R.W. Emergence of carbapenem-resistant Acinetobacter baumannii ST195 harboring blaOxa-23 isolated from bacteremia in Hong Kong. Microb. Drug Resist. 2019, 25, 1199–1203.

- Skiebe E, de Berardinis V, Morczinek P, Kerrinnes T, Faber F, Lepka D, et al. Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii, depends on 1,3-diaminopropane. Int J Med Microbiol, 2012,302 (3):117–28.

- U, Skiebe E, Wilharm G. Novel Genes Required for Surface-Associated Motility in Acinetobacter baumannii. Curr Microbiol. 2021,78 (4):1509-1528.

- Corral J, Pérez-Varela M, Barbé J, Aranda J. Direct interaction between RecA and a CheW-like protein is required for surface-associated motility, chemotaxis and the full virulence of Acinetobacter baumannii strain ATCC 17978. Virulence. 2020,11 (1):315-326.

- Vijayakumar S, Rajenderan S, Laishram S, Anandan S, Balaji V, Biswas I. Biofilm formation and motility depend on the nature of the Acinetobacter baumannii clinical isolates. Front Public Health 2016; 4:105

- Giles S K, Stroeher UH, Eijkelkamp BA, Brown MH. Identification of genes essential for pellicle formation in Acinetobacter baumannii. BMC Microbiol. 2015, 6;15:116.

- Chen R, Lv R, Xiao L, Wang M, Du Z, Tan, Y., et al. A1S_2811, a CheA/Y-like hybrid two-component regulator from Acinetobacter baumannii ATCC17978, is involved in surface motility and biofilm formation in this bacterium. Microbiologyopen. 2017; 6 (5).




How to Cite

Sajad Numan, Al-Saedi, F., Israa Burhan, & Mojtaba Mohammadzadeh Vazifeh. (2024). Virulence Determinants of Acinetobacter baumannii Isolated from Different Infections in Baghdad Hospitals . Al Mustansiriyah Journal of Pharmaceutical Sciences, 24(3), 264–273.